Detalhe da pesquisa
1.
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Biol Blood Marrow Transplant
; 26(10): 1930-1936, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32649981
2.
The clinical impact of donor-specific antibodies on antibody-mediated rejection and long-term prognosis after heart transplantation.
Curr Opin Organ Transplant
; 24(3): 245-251, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31090631
3.
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 22(4): 698-704, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26785332
4.
Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.
Blood
; 123(1): 133-40, 2014 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-24141369
5.
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.
Blood
; 123(8): 1270-8, 2014 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-24408320
6.
Growing evidence that 2-field high-resolution HLA typing is important for kidney transplantation.
Am J Transplant
; 20(12): 3277-3278, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32484291
7.
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.
Blood
; 121(22): 4603-10, 2013 May 30.
Artigo
Inglês
| MEDLINE | ID: mdl-23596045
8.
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
Blood
; 122(22): 3651-8, 2013 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-23982174
9.
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
Pediatr Blood Cancer
; 61(7): 1289-94, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24623601
10.
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
Biol Blood Marrow Transplant
; 19(4): 552-61, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23253557
11.
Next generation multiplexing for digital PCR using a novel melt-based hairpin probe design.
Front Genet
; 14: 1272964, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38028620
12.
HLA diversity in ethnic populations can affect detection of donor-specific antibodies by single antigen beads.
Front Immunol
; 14: 1287028, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38077376
13.
Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.
J Exp Med
; 203(4): 961-71, 2006 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-16585267
14.
Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 18(5): 739-46, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21963622
15.
Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.
Biol Blood Marrow Transplant
; 18(11): 1656-63, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22609040
16.
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
Biol Blood Marrow Transplant
; 18(2): 324-9, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22079471
17.
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.
Biol Blood Marrow Transplant
; 18(12): 1890-6, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22814031
18.
T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients.
Br J Haematol
; 157(2): 205-19, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22313507
19.
Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.
Biomark Med
; 16(5): 401-415, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35195028
20.
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease.
Front Immunol
; 13: 1055497, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36569951